Who we are
Lucent Diagnostics, a Quanterix brand, is pioneering ultra-sensitive, blood-based biomarker testing for Alzheimer’s disease. Using Simoa® Technology, we empower providers with earlier, more accurate detection, enabling better patient outcomes.
Our mission
We are committed to transforming Alzheimer’s detection and diagnosis through cutting edge biomarker testing. Our goal is to make highly-sensitive, accessible blood tests the new standard of care, reducing reliance on invasive procedures.
About Quanterix
Quanterix is on a mission to change the way in which healthcare is provided by giving researchers the ability to closely examine the continuum from health to disease. In order to make this vision a reality, we brought together an experienced management team, renowned scientists, industry leading investors and expert advisors, to form a collaborative ecosystem, united through the common goal of advancing the science of precision health.
With hundreds of academic and industry customers around the globe, Quanterix provides direct sales and service to customers in North America and Europe. Our products and services are available globally through our distributor partners. Our team of field applications scientists and engineers supports our customers in all corners of the world.
